ICON is a global provider of outsourced drug development services to Biopharma, Medical Device, Government, Biosimilar and Generic Organisations.
We have a strong record of managing Pharmacovigilance throughout the entire lifecycle of a drug.
Our exceptional teams are thoroughly experienced in case processing, database migrations, pharmacovigilance intelligence, EudraVigilance services, end to end global safety reporting, QPPV services, literature services, medical writing, medical publishing and affiliate management, covering both Clinical Trials and Post-Marketing products.
We cover a complete range of Pharmacovigilance services including virtual Pharmacovigilance departments through to global Pharmacovigilance affiliate management.
Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. At ICON, our core value is patient safety, which we achieve via a Trusted Partnership with our Clients and the seamless contribution by our team to your Quality Management System.
Our exceptional Pharmacovigilance department includes a dedicated Safety Reporting Quality Assurance team safeguarding continuously excellent inspection outcomes. Our asset to Pharmacovigilance is unique to the industry due to our integrated and dedicated Pharmacovigilance Intelligence and Regulatory Change Management teams to support you in an ever changing environment to sustain compliance.